Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Protease Inhibitor”

523 trials

Showing 20 of 523 results

Not applicableStudy completedNCT00886990
What this trial is testing

Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens

Who this might be right for
HIV InfectionHIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 240
Early research (Phase 1)Study completedNCT00000887
What this trial is testing

Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT00259727
What this trial is testing

The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism

Who this might be right for
DiabetesHIV InfectionsInsulin Resistance
US Department of Veterans Affairs 80
Large-scale testing (Phase 3)Study completedNCT00460746
What this trial is testing

Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.

Who this might be right for
HIV
Tibotec, Inc 10
Early research (Phase 1)Study completedNCT00000941
What this trial is testing

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Large-scale testing (Phase 3)Ended earlyNCT04723537
What this trial is testing

Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease

Who this might be right for
Covid19
RedHill Biopharma Limited 61
Not applicableStudy completedNCT02191332
What this trial is testing

Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen

Who this might be right for
HIV Infections
Boehringer Ingelheim 147
Large-scale testing (Phase 3)Study completedNCT00038519
What this trial is testing

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

Who this might be right for
HIV Infections
Abbott 16
Not applicableStudy completedNCT00000892
What this trial is testing

Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)Study completedNCT00196612
What this trial is testing

Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 350
Testing effectiveness (Phase 2)Study completedNCT00002240
What this trial is testing

Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Not applicableStudy completedNCT00884793
What this trial is testing

Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut

Who this might be right for
HIV Infections
University of California, San Francisco 8
Not applicableUnknownNCT03146208
What this trial is testing

Role of Endothelial Biomarkers in Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery DiseaseDiabetes MellitusCytomegalovirus Infections
Assiut University 54
Early research (Phase 1)Study completedNCT01288417
What this trial is testing

Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir

Who this might be right for
HIV InfectionsHCV Infections
Radboud University Medical Center 24
Large-scale testing (Phase 3)Ended earlyNCT00144833
What this trial is testing

Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects

Who this might be right for
HIV-1
GlaxoSmithKline 150
Testing effectiveness (Phase 2)Study completedNCT01271790
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 245
Early research (Phase 1)Study completedNCT00002380
What this trial is testing

The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Who this might be right for
HIV Infections
Hoffmann-La Roche 28
Early research (Phase 1)Study completedNCT00774735
What this trial is testing

GSK1349572 Drug Interaction Study With Protease Inhibitors

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Ended earlyNCT00513513
What this trial is testing

TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 7
Early research (Phase 1)Ended earlyNCT01086332
What this trial is testing

Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
University of Iowa 7
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation